AHL
GH icon

Abel Hall LLC’s Guardant Health GH Stock Holding History

Abel Hall LLC’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$420K Buy
4,551
+18
+0.4% +$1.81K 0.09% 255
2025
Q4 		$463K Buy
4,533
+751
+20% +$67.2K 0.11% 192
2025
Q3 		$236K Sell
3,782
-100
-3% -$5.44K 0.1% 231
2025
Q2 		$202K Buy
+3,882
New +$173K 0.09% 232

Other funds holding GH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Abel Hall LLC's GH Position: Q1 2026 in Review

Abel Hall LLC increased its Guardant Health (GH) stake by 0.4% in Q1 2026, buying an estimated $1.81K and bringing the position to 4,551 shares worth $420K. The position accounts for 0.09% of the portfolio, ranked #255.

Abel Hall LLC first reported a position in GH in Q2 2025 and has held it in 4 quarters since. The position peaked at $463K in Q4 2025. 481 funds tracked by Wall St. Rank hold GH as of Q1 2026.

  • Abel Hall LLC held 4,551 shares of Guardant Health worth $420K as of Q1 2026.
  • Abel Hall LLC bought 18 Guardant Health shares in Q1 2026, an estimated $1.81K.
  • Guardant Health made up 0.09% of Abel Hall LLC's portfolio in Q1 2026, its #255 holding.
  • Abel Hall LLC first reported a position in Guardant Health in Q2 2025 and has held it in 4 quarters since.
  • Abel Hall LLC's Guardant Health position peaked at $463K in Q4 2025.
  • 481 funds tracked by Wall St. Rank held Guardant Health as of Q1 2026.

Based on Abel Hall LLC's 13F filing for Q1 2026, filed 28 Apr 2026.